Hinrich Wilhelm Helmut Göhlmann

Title: The Innovations of Hinrich Wilhelm Helmut Göhlmann

Introduction

Hinrich Wilhelm Helmut Göhlmann is a notable inventor based in s'Hertogenbosch, Netherlands. He has made significant contributions to the field of biotechnology, particularly in the development of pharmaceutical compositions. His work focuses on the interaction of proteins and their potential applications in treating diseases.

Latest Patents

Göhlmann holds a patent for the invention titled "Bacterial ATP synthase binding domain." This invention provides an isolated mutant atpE protein and identifies an ATPase binding domain derived from said mutant atpE protein. Additionally, it includes related nucleic acids, vectors, host cells, pharmaceutical compositions, and articles of manufacture. The invention also outlines methods for determining whether a test compound interacts with the atpE protein, specifically with the ATPase binding domain. This has implications for pharmaceuticals, particularly as antimicrobials and more specifically as antimycobacterial agents for treating tuberculosis in subjects.

Career Highlights

Göhlmann is currently employed at Janssen Pharmaceutica NV, where he continues to innovate in the pharmaceutical sector. His work is crucial in advancing treatments for infectious diseases, showcasing his commitment to improving public health through scientific research.

Collaborations

He collaborates with esteemed colleagues, including Koenraad Jozef Lodewijk Marcel Andries and Jean-Marc Edmond Fernand Marie Neefs. These partnerships enhance the research and development efforts at Janssen Pharmaceutica NV.

Conclusion

Hinrich Wilhelm Helmut Göhlmann's contributions to biotechnology and pharmaceuticals are noteworthy. His innovative patent on the bacterial ATP synthase binding domain exemplifies his dedication to advancing medical science. His work continues to have a significant impact on the treatment of tuberculosis and other infectious diseases.